The Role of Triple Therapy in Respiratory Disease: COPD

Course Details

Chronic Obstructive Pulmonary Disease (COPD) is a significant health issue in the Australian community, and patients often continue to experience debilitating symptoms despite standard therapy. Healthscope, in collaboration with their Respiratory Physicians, have launched a new 3.5-hour CPD activity to help you navigate this important area of respiratory medicine.

In this interactive CPD module, we’re exploring “The role of triple therapy in respiratory disease: COPD”, focusing on the multi-system impact of the condition and the evidence-based management strategies that can improve patient outcomes. This CPD activity is accredited for both Specialists and GPs.

Learning Outcomes:

  1. Review the incidence and prevalence of COPD in the Australian community
  2. Review the multi-system impact of COPD on patients with the condition
  3. Outline current treatment and management regimes for patients with COPD

This is a RACGP CPD module with an allocated 0.5 hours of Education Activities (EA), 2 hour of Measuring Outcomes (MO), and 1 hour of Reflective Practice (RP) under the RACGP 2023-25 CPD program.

This activity was recorded in August 2025.

Register or login to gain access to this course

New to MEDD?
>

We value your privacy

We use cookies to enhance your browsing experience, serve personalized ads or content, and analyze our traffic. By using MEDD, you consent to our use of cookies. To find out more about the cookies we use, please see our Privacy Policy